human vaccines & immunotherapeutics

international journal of audiology

Antiviral research

[1] Herpes zoster does not increase the risk of sudden sensory neural hearing loss: a longitudinal follow-up study using a national sample cohort.

[2] Viral ribonucleotide reductase attenuates the anti-herpes activity of acyclovir in contrast to amenamevir.

[3] do herpes e suas implicações audiológicas: uma revisao de literatura herpes and its hearing implications: a literature review

[4] a cross-sectional study of dermatological manifestations in children with human immunodeficiency virus/acquired immunodeficiency syndrome

[5] predictors of postherpetic neuralgia in patients with herpes zoster: a pooled analysis of prospective cohort studies from north and latin america and asia

[6] management of ramsay hunt syndrome in an acute palliative care setting

[7] herpes zoster could be an early manifestation of undiagnosed human immunodeficiency virus infection

[8] incidences of herpes zoster and postherpetic neuralgia in japanese adults aged 50 years and older from a community-based prospective cohort study: the shez study

[9] incidence of herpes zoster in relationship with climate factors from 2009 to 2011

[10] A novel nonlive, adjuvanted herpes zoster subunit vaccine: a report on the emerging clinical data and safety profile

[11] A novel nonlive, adjuvanted herpes zoster subunit vaccine: a report on the emerging clinical data and safety profile

[12] THE POTENTIAL PUBLIC HEALTH IMPACT OF HERPES ZOSTER VACCINATION IN THE 65 YEARS OF AGE COHORT IN ITALY.

[13] Herpes zoster: Risk and prevention during immunomodulating therapy.

[14] Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long term follow up.

[15] Herpes zoster: Risk and prevention during immunomodulating therapy

[16] Herpes zoster does not increase the risk of sudden sensory neural hearing loss: a longitudinal follow-up study using a national sample cohort.

[17] Herpes zoster in Germany: Quantifying the burden of disease

[18] herpes zoster ophthalmicus with sixth cranial nerve palsy: a case report

[19] orbital apex syndrome secondary to herpes zoster ophthalmicus

[20] a rare complication of herpes zoster: segmental zoster paresis

[21] reactive perforating collagenosis with a giant lesion at the site of healed herpes zoster

[22] oral acyclovir versus placebo in acute herpes zoster

[23] comment: herpes zoster ophthalmicus: clinical profile in adults less than 30 years of age

[24] predictors of postherpetic neuralgia in patients with herpes zoster: a pooled analysis of prospective cohort studies from north and latin america and asia

[25] herpes zoster and postherpetic neuralgia: past, present and future

[26] joven mujer con mioclonías, pérdida de sensibilidad, hemiparesia derecha y convulsiones tras dos episodios consecutivos de herpes zoster.

[27] a specific vaccine to protect patients with multiple sclerosis from herpes zoster

[28] herpes zoster could be an early manifestation of undiagnosed human immunodeficiency virus infection

[29] herpes zoster meningitis complicating combined tocilizumab and cyclosporine therapy for adult-onset still’s disease

[30] incidences of herpes zoster and postherpetic neuralgia in japanese adults aged 50 years and older from a community-based prospective cohort study: the shez study

[31] incidence of herpes zoster in relationship with climate factors from 2009 to 2011

[32] myiasis complicating herpes zoster in an immuno compromised patient

[33] Herpes zoster infection in HIV-seropositive patients associated with highly active antiretroviral therapy